| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/11/2006 | EP1613270A2 Film forming polymers, methods of use, and devices and applications thereof |
| 01/11/2006 | EP1613269A2 Compositions, methods and kits relating to her-2 cleavage |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1613267A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 01/11/2006 | EP1613265A2 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613264A2 Gaucher disease drugs and methods of identifying same |
| 01/11/2006 | EP1613263A2 Monitoring and treatment of amyotrophic lateral sclerosis |
| 01/11/2006 | EP1613261A2 Intracellular formation of peptide conjugates |
| 01/11/2006 | EP1613159A2 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-fungal agents |
| 01/11/2006 | EP1613155A2 Treatment of demyelinating conditions |
| 01/11/2006 | EP1560498A4 Chewing gum compositions with encapsulated stain removing agent |
| 01/11/2006 | CN1720242A Synthetic lactone formulations and method of use |
| 01/11/2006 | CN1720226A Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 01/11/2006 | CN1720060A Human papillomavirus polypeptides and immunogenic compositions |
| 01/11/2006 | CN1720048A Method and compositions for treating anxiety |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/10/2006 | US6984377 Oral care products comprising calcium metasilicates |
| 01/05/2006 | WO2006001766A1 Composition comprising lactic acid and lactoferrin |
| 01/05/2006 | WO2005071070A3 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors |
| 01/05/2006 | WO2005055929A3 Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 01/05/2006 | WO2005051324A3 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 01/05/2006 | WO2005048915A3 Renoprotective and lipid lowering oral compositions |
| 01/05/2006 | WO2005037211A3 Methods and compositions for the treatment of neurological disease |
| 01/05/2006 | WO2005016280A3 Orally administered small peptides synergize statin activity |
| 01/05/2006 | WO2005016268A3 Alimentary compositions and methods for metabolic modulation |
| 01/05/2006 | WO2005011571A3 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 01/05/2006 | WO2005009377A3 Novel oral bioavailable prodrugs |
| 01/05/2006 | WO2005009345A3 2-desmethyl ansamycin compounds |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | WO2004089301A3 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2004069148A3 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids |
| 01/05/2006 | WO2004066928A3 Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals |
| 01/05/2006 | WO2004040997A3 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine |
| 01/05/2006 | US20060004040 Method for the prevention and/or treatment of atherosclerosis |
| 01/05/2006 | US20060004036 Sigma-2 receptor agonists and their use in the treatment of HIV infection |
| 01/05/2006 | US20060003985 Enhancement of sleep with t-type calcium channel antagonists |
| 01/05/2006 | US20060002995 Pharmaceutical porous particles |
| 01/05/2006 | US20060002961 Immunogens; Streptococcus pneumoniae polysaccharide-protein conjugate/antigen, and adjuvant which induces (cytotoxic T) lymphocytes |
| 01/05/2006 | US20060002854 Conjugate of therapeutic moiety linked to peptide having the amino acid sequence CGKRK, length < 400 residues, or a conservative variant or peptidomimetic; anticarcinogenic, -tumor agents; tissue-targeted therapy; side effect reduction; binds cognate receptor; angiogenesis inhibitors |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | CA2571183A1 Composition comprising lactic acid and lactoferrin |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1611123A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1610808A2 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 01/04/2006 | EP1610806A2 Method of treating cancer with azaspirane compositions |
| 01/04/2006 | EP1610804A2 Igf-binding protein-derived peptide or small molecule |
| 01/04/2006 | EP1610800A2 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/04/2006 | EP1610796A2 High potency dopaminergic treatment of neurological impairment associated with brain injury |
| 01/04/2006 | EP1610784A2 Forms of 5-azacytidine |
| 01/04/2006 | EP1610778A2 Treatment of benign prostatic hyperplasia |
| 01/04/2006 | EP1610776A2 Ophthalmic compositions for treating ocular hypertension |
| 01/04/2006 | EP1610772A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 01/04/2006 | EP1610760A2 Topical l-carnitine compositions |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1610758A2 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 01/04/2006 | EP1610757A2 Profiling conformational variants, antibody compositions and methods of using the same |
| 01/04/2006 | EP1610755A2 Phosphodiesterase 2a and methods of use |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1610752A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 01/04/2006 | EP1610742A2 Methods and compositions for administration of trpv1 agonists |
| 01/04/2006 | EP1383741A4 Process for the preparation of benazepril |
| 01/04/2006 | EP1237553B1 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 01/04/2006 | EP1131051B1 Pressurised metered dose inhalers (mdi) |
| 01/04/2006 | CN1717405A Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 01/04/2006 | CN1717251A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 01/04/2006 | CN1717240A New use of dextran sulfate |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714791A Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 01/03/2006 | US6982255 Comprises coadministration of galactomannan and chemotherapeutic agent (adriamycin) |
| 01/03/2006 | US6982254 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 12/29/2005 | WO2005058244A3 Novel anti-dc-sign antibodies |
| 12/29/2005 | WO2005058242A3 Chewable soft capsules containing ungelatinized starch |
| 12/29/2005 | WO2005055939A3 Vinca derivatives |
| 12/29/2005 | WO2005048943A3 Compositions and methods for synergistic induction of antitumor immunity |
| 12/29/2005 | WO2005046618A3 Methods of treating eczema |
| 12/29/2005 | WO2005046608B1 Novel compound, corresponding compositions, preparation and/or treatment methods |
| 12/29/2005 | WO2005046595A3 Hif-1 inhibitors and methods of use thereof |
| 12/29/2005 | WO2005046587A3 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 12/29/2005 | WO2005046580A3 Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism |
| 12/29/2005 | WO2005037190A3 Multiplex vaccines |
| 12/29/2005 | WO2005034881A3 Methods and compositions for treating conditions involving abnormal angiogenesis |
| 12/29/2005 | WO2005034879A3 Treatment of diseases involving erbb2 kinase overexpression |
| 12/29/2005 | WO2005032480A3 Methods, compositions,, apparatuses containing tetrameric oxygen |
| 12/29/2005 | WO2005020883A3 Methods for the production of ansamitocins |
| 12/29/2005 | WO2005018563A3 Compositions of a cyclooxygenase-2 selective inhibitor and a phosphodiesterase inhibitor for the treatment of ischemic mediated central nervous system disorders or injury |
| 12/29/2005 | WO2005018562A3 Blockade of mtor to prevent a hormonal adaptive response |
| 12/29/2005 | WO2005016273A3 Infection prophylaxis using immune response modifier compounds |
| 12/29/2005 | WO2005016243A3 Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disorders |
| 12/29/2005 | WO2005013918A3 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 12/29/2005 | WO2005011618A3 Methods for the treatment of male and female sexual dysfunction |
| 12/29/2005 | WO2005004814A3 Sirt1 and genetic disorders |
| 12/29/2005 | WO2005000203A3 Methods for treating cognitive impairment and improving cognition |
| 12/29/2005 | WO2004108076A3 Anti-hiv benzamide compounds |
| 12/29/2005 | WO2004103269A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |